Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
You can email us or fill out the form below and we will get back to you as soon as possible!
and it has demonstrated analgesic properties in animal studies
BPC-157 is frequently studied in combination with the TB-500 (thymosin beta-4) for tissue regeneration, the GHK-Cu for skin healing and angiogenesis, the KPV for anti-inflammatory gastrointestinal applications, and the Thymosin Alpha-1 for immunomodulation
By activating these receptors in the brains satiety centers (like the area postrema), it promotes feelings of fullness, reduces food intake, and helps stabilize post-meal blood sugar spikes, making it a promising candidate for weight management, particularly in combination with the GLP-1 receptor agonist semaglutide (marketed as CagriSema)
Mean body-weight change was 14.9% with semaglutide versus 2.4% with placebo an estimated treatment difference of about 12.4 percentage points with most of the semaglutide group reaching at least 5% or 10% weight loss and about half reaching 15%
US$ 29.38
US$ 23.69
US$ 25.12
US$ 22.90
